跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
菲新捷 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ferric Carboxymaltose Injection
Approved
化学药品
Ferric Carboxymaltose Injection
Vifor (International) AG
🇨🇳 National Medical Products Administration
Approval Date
Nov 22, 2022
Approval ID
32578bcfb1149052
Company
Vifor (International) AG
Type
化学药品
Approval Details
Approval Id
32578bcfb1149052
Approval Number
国药准字HJ20220091
Generic Name
羧基麦芽糖铁注射液
Generic Name En
Ferric Carboxymaltose Injection
Trade Name
菲新捷
Drug Type
化学药品
Dosage Form
注射剂
Strength
按Fe计 10mL:500mg
Reg Date
2022-11-22
Expired Date
2027-11-21
Company Name
Vifor (International) AG
Production Company Name
IDT Biologika GmbH
Company Detail Path
/organization/vifor-international-ag
Production Company Detail Path
/organization/idt-biologika-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 22, 2022
Approval ID
32578bcfb1149052
Type
化学药品
Back to NMPA Approvals